The U.S. Defense Logistics Agency (DLA) awarded a $20,646.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pulmozyme, a medication used to treat cystic fibrosis, with a performance period through December 2024. This award is a delivery order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. The contract award does not have a set-aside designation, indicating open competition.
Generated 3/23/25, 12:52 AM